StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.71+0.08 (+12.14%)

Close on Nov 18, 2026Market cap $5.36MP/E –Yield –

Cerenome price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cerenome's price to sales ratio was 1.4× on Nov 11, 2026, against 15.3× a year earlier. Over the last 5 years it ranged from 0.0× to 192.7×, with a median of 0.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.4×−11.4
2025Dec 31, 202512.8×+12.8
2019Oct 31, 20190.0×−0.1
2018Dec 31, 20180.1×−0.1
2017Dec 29, 20170.2×−0.2
2016Dec 30, 20160.4×–

More Cerenome figures

See a number that looks wrong?